Fernanda Ortiz

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Bengt Fellström, Jonathan Barratt, H. Terence Cook et al. · The Lancet · 2017 · 402 citations · Full text

Medicine, Nephrology, Pharmacotherapy +10

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial

Peter Vink, Josep Ramón, Ana Sánchez‐Fructuoso et al. · Clinical Infectious Diseases · 2019 · 194 citations · Full text

Medicine, Immunology, Nephrology +15

Biochemical pathways of breath ammonia (NH₃) generation in patients with end-stage renal disease undergoing hemodialysis

W Chen, Saara Laiho, Olavi Vaittinen et al. · Journal of Breath Research · 2016 · 59 citations

Medicine, Biochemistry, Nephrology +14

Health-related quality of life after kidney transplantation: who benefits the most?

Fernanda Ortiz, Pasi Aronen, Petri Koskinen et al. · Transplant International · 2014 · 57 citations · Full text

Medicine, Nephrology, Surgery +14